Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Henry J. Fuchs currently holds 185,074 shares of Mirati Therapeutics, Inc. (MRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Henry J. Fuchs has been a net seller of MRTX stock. They have purchased $0 and sold $77.2M worth of shares.
Henry J. Fuchs's most recent insider trade was on Sep 13, 2024, when they sold 12,098 shares at $84.90 per share.
Henry J. Fuchs serves as Executive at Mirati Therapeutics, Inc. (MRTX). They have executed 402 insider transactions totaling $77.2M over their tenure at the company.
Henry J. Fuchs holds the position of Executive at Mirati Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Henry J. Fuchs has shown a selling trading pattern, with $0 in total purchases and $77.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Henry J. Fuchs was on Mar 16, 2023, when they sold $3.4M worth of BMRN shares. This transaction involved 36,000 shares at $93.41 per share.
Henry J. Fuchs currently owns 185,074 shares of Mirati Therapeutics, Inc. (MRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Henry J. Fuchs's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Henry J. Fuchs has 402 Form 4 filings on record as an insider at Mirati Therapeutics, Inc..
Set alerts for Henry J. Fuchs and 40,000+ other insiders.